As expected, and in accordance with the literature data [5,28,29,30], the established biomarkers TPA and CA-125 showed elevated concentrations in malignant tumors as compared to healthy women and benign diseases, with median values of uterine cancer being moderately elevated and those of ovarian cancer being strongly elevated. The gene discussed is MUC16; the disease is ovarian carcinoma.